Sudden bilateral sensorineural hearing loss during treatment with dantrolene sodium (dantrium).
Pace-Balzan
A
A
Department of Otolaryngology, Manchester Royal Infirmary.
Ramsden
R T
RT
D000328:Adult; D002547:Cerebral Palsy / Q000188:drug therapy; D003620:Dantrolene / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D003639:Hearing Loss, Sudden / Q000139:chemically induced*; D006801:Humans
D003620:Dantrolene